Heterocyclische Verbindungen aus Zuckern, XV: Zur Konfiguration chiraler C-2-substituierter 4-Thiazolidincarbons�uren. Chiralit�tstransfer auf C-3 in 3,4-Dihydro-1H-pyrrolo[1,2-c]thiazolen
摘要:
5-Substituted 3,4-dihydro-pyrrolo[1,2-c]thiazole-6,7-dicarboxylic acid esters 3 are obtained from 2-substituted-3-acyl-1,3-thiazolidine-4-carboxylic acids, 1 in [3 + 2]-cycloaddition reactions via mesoionic oxazolone (''munchnone'') intermediates. The chirality at C-4 of the starting carboxylic acids 1 is eliminated in the products 3, and the chirality at C-3 (C-2 in the starting carboxylic acids 1) can thus be determined through chiroptical measurements. Several representatives of the ring system 3 have been characterised through H-1- and CD-spectra and the molecular structure of (3S)-3da has been determined by X-ray crystallography.
THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS
申请人:Miller Duane D.
公开号:US20080255213A1
公开(公告)日:2008-10-16
Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides having a structure
where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
S-메틸메티오닌 설포늄의 유도체를 유효성분으로 포함하는 자외선에 의한 피부 손상 억제 및 피부 보호용 화장료 조성물
申请人:UIF (University Industry Foundation), Yonsei University 연세대학교 산학협력단(220050095099) BRN ▼110-82-10500
公开号:KR20180019310A
公开(公告)日:2018-02-26
본 발명은 S-메틸메티오닌 설포늄(S-Methylmethionine sulfonium, SMMS)의 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 자외선에 의한 피부 손상 억제 및 피부 보호용 조성물에 관한 것으로, 보다 상세하게는 자외선에 의한 피부 손상 억제 및 피부 보호용 화장료 조성물, 의약외품 및 약학적 조성물을 제공한다.
The invention is in the field of growth of Mycobacteria. In particular, agents have been identified which enhance the growth of Mycobacterial species, which are naturally slow-growing. Such agents can therefore be used in the identification of Mycobacteria and in the diagnosis of Mycobacterial infections.